Walter & Keenan Financial Consulting Co. MI ADV Has $671,000 Stake in UnitedHealth Group Inc (NYSE:UNH)

Walter & Keenan Financial Consulting Co. MI ADV boosted its holdings in UnitedHealth Group Inc (NYSE:UNH) by 27.9% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,750 shares of the healthcare conglomerate’s stock after purchasing an additional 600 shares during the quarter. Walter & Keenan Financial Consulting Co. MI ADV’s holdings in UnitedHealth Group were worth $671,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of UNH. California State Teachers Retirement System lifted its position in UnitedHealth Group by 1.8% during the 4th quarter. California State Teachers Retirement System now owns 1,719,981 shares of the healthcare conglomerate’s stock worth $428,482,000 after acquiring an additional 31,097 shares during the period. Magnus Financial Group LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $1,090,000. Vivaldi Capital Management LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $583,000. Mader & Shannon Wealth Management Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $3,569,000. Finally, Fort L.P. lifted its position in UnitedHealth Group by 74.5% during the 4th quarter. Fort L.P. now owns 6,423 shares of the healthcare conglomerate’s stock worth $1,600,000 after acquiring an additional 2,742 shares during the period. Institutional investors and hedge funds own 85.65% of the company’s stock.

In related news, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $248.00, for a total value of $2,480,000.00. Following the completion of the transaction, the director now directly owns 187,663 shares of the company’s stock, valued at approximately $46,540,424. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $246.40, for a total value of $1,232,000.00. Following the completion of the transaction, the director now directly owns 187,979 shares of the company’s stock, valued at $46,318,025.60. The disclosure for this sale can be found here. Insiders sold a total of 37,000 shares of company stock valued at $9,195,620 over the last ninety days. 0.82% of the stock is currently owned by company insiders.

A number of research firms have weighed in on UNH. Raymond James increased their price objective on UnitedHealth Group from $265.00 to $300.00 and gave the stock a “buy” rating in a research report on Friday, July 19th. ValuEngine cut UnitedHealth Group from a “hold” rating to a “sell” rating in a research report on Thursday, April 18th. SunTrust Banks cut their target price on UnitedHealth Group to $300.00 and set a “buy” rating for the company in a research note on Wednesday, April 17th. They noted that the move was a valuation call. Cantor Fitzgerald set a $310.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. Finally, Royal Bank of Canada set a $311.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $295.06.

Shares of UNH stock traded up $2.53 during trading hours on Wednesday, reaching $245.73. 1,070,816 shares of the company’s stock were exchanged, compared to its average volume of 4,651,164. The firm has a market cap of $235.62 billion, a P/E ratio of 19.08, a P/E/G ratio of 1.33 and a beta of 0.61. The business’s 50 day simple moving average is $251.38. UnitedHealth Group Inc has a 1 year low of $208.07 and a 1 year high of $287.94. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.67 and a current ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating the consensus estimate of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The firm had revenue of $60.60 billion during the quarter, compared to the consensus estimate of $60.59 billion. During the same period last year, the business posted $3.14 EPS. UnitedHealth Group’s quarterly revenue was up 8.0% on a year-over-year basis. Sell-side analysts forecast that UnitedHealth Group Inc will post 14.82 EPS for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: What is a portfolio manager?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.